WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...

Research links weight loss medications like Ozempic and Zepbound to certain serious eye conditions.

open image in gallery A small percentage of patients taking weight loss and diabetes drugs like Ozempic and Zepbound have experienced ... study published late last month in the journal JAMA ...

People taking weight-loss drugs say they are losing their sight. Science is trying to figure out why - There’s no direct link ...

Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Eli Lilly and Company’s LLY shares have risen 4.3% since it reported fourth-quarter results on Feb. 6. Lilly’s fourth-quarter ...

Since its online debut late last month, the one-minute ad pitching ... leaving people who take the cheaper version in a bind. Zepbound, another weight-loss drug, was taken off the compounding ...

The increase in weight loss with the higher dose was impressive, but still lower than has been achieved in clinical trials of Eli Lilly's rival obesity therapy Zepbound (tirzepatide), which helped ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

the active ingredient in Eli Lilly’s popular weight loss medication Zepbound and diabetes drug Mounjaro. After months of high demand and supply constraints, this news marks a significant ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don ...